Literature DB >> 11410119

Polymorphism in the gelatinase B gene and the severity of coronary arterial stenosis.

J Wang1, D Warzecha, D Wilcken, X L Wang.   

Abstract

Gelatinase B, as one of the matrix metalloproteinases, may be relevant to atherogenic plaque development and stability. Recently, a C-1562T substitution in the regulatory region of the gelatinase B gene was shown to up-regulate gelatinase B expression, which could be relevant to both the severity and stability of atherosclerotic plaques. We determined the genotype of 788 angiographically documented Caucasian patients with coronary artery disease (583 males and 205 females; age 56.7+/-0.4 years). The proportions of C/C (77.1%), C/T (21.4%) and T/T (1.5%) genotypes were in Hardy-Weinberg equilibrium, and did not differ between males and females (P>0.05). The frequencies of the rare T allele in patients with angiographically documented coronary artery disease (0.123), a past history of myocardial infarction (0.128) or unstable angina (0.128) were not significantly different from those in patients without such events (0.121, 0.118 and 0.128 respectively; P>0.05). In addition, the rare allele frequencies among patients with no (0.128), one (0.124), two (0.108) or three (0.121) significantly diseased vessels (> or =50% luminal obstruction) were not statistically different (P=0.932). However, the male rare T/T homozygotes had lower waist/hip ratios and levels of high-density lipoprotein cholesterol (HDL-C), and higher total cholesterol/HDL-C ratios, than C/C homozygotes (P<0.05). In conclusion, our study in a large series of angiographically defined patients suggests that the C-1562T polymorphism may not be useful as a predictor of the presence and severity of coronary atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11410119

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  9 in total

1.  Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease.

Authors:  Benjamin D Horne; Nicola J Camp; John F Carlquist; Joseph B Muhlestein; Matthew J Kolek; Zachary P Nicholas; Jeffrey L Anderson
Journal:  Am Heart J       Date:  2007-10       Impact factor: 4.749

Review 2.  The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis.

Authors:  Sonia Abilleira; Steve Bevan; Hugh S Markus
Journal:  J Med Genet       Date:  2006-08-11       Impact factor: 6.318

3.  Functional polymorphisms of matrix metallopeptidase-9 and risk of coronary artery disease in a Chinese population.

Authors:  Hong Zhi; Hua Wang; Liqun Ren; Zhiyang Shi; Haiyan Peng; Lunbiao Cui; Genshan Ma; Xingzhou Ye; Yi Feng; Chengxing Shen; Xiangjun Zhai; Chenyu Zhang; Ke Zen; Naifeng Liu
Journal:  Mol Biol Rep       Date:  2009-03-13       Impact factor: 2.316

4.  Association of MMP-9 gene polymorphisms with acute coronary syndrome in the Uygur population of China.

Authors:  Lei Wang; Yi-Tong Ma; Xiang Xie; Yi-Ning Yang; Zhen-Yan Fu; Fen Liu; Xiao-Mei Li; Bang-Dang Chen
Journal:  World J Emerg Med       Date:  2011

Review 5.  Association of matrix metalloproteinase-9 C1562T polymorphism and coronary artery disease: a meta-analysis.

Authors:  Xiao Wang; Lei-zhi Shi
Journal:  J Zhejiang Univ Sci B       Date:  2014-03       Impact factor: 3.066

6.  Association between matrix metalloproteinase 9 C-1562T polymorphism and the risk of coronary artery disease: an update systematic review and meta-analysis.

Authors:  Ming-Ming Zhang; Xue-Wei Chang; Xue-Qin Hao; Hao Wang; Xiang Xie; Shou-Yan Zhang
Journal:  Oncotarget       Date:  2017-12-15

7.  The association between Matrix Metallo-proteinases-9 (MMP-9) gene family polymorphisms and risk of Coronary Artery Disease (CAD): a systematic review and meta-analysis.

Authors:  Reza Hassanzadeh-Makoui; Bahman Razi; Saeed Aslani; Danyal Imani; Seyedeh Samaneh Tabaee
Journal:  BMC Cardiovasc Disord       Date:  2020-05-19       Impact factor: 2.298

8.  PR3 levels are impaired in plasma and PBMCs from Arabs with cardiovascular diseases.

Authors:  Abdelkrim Khadir; Dhanya Madhu; Sina Kavalakatt; Preethi Cherian; Monira Alarouj; Abdullah Bennakhi; Jehad Abubaker; Ali Tiss; Naser Elkum
Journal:  PLoS One       Date:  2020-01-14       Impact factor: 3.240

9.  Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease.

Authors:  Jeong-Ah Park; Kyung-Sue Shin; Youn Woo Kim
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.